TNON Stock Catalyst: Tenon Medical Granted U.S. Patent for Sacroiliac Joint Stabilization Systems

Aug 18, 2026 · 6:48am ET

The company received a Notice of Allowance for its innovative medical device.

Max move

+98.0%

High of day $10.10

Sparker timei

6:48am ET

TNON · Aug 18, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Tenon Medical, Inc. (Nasdaq: TNON) announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent titled "Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints". This recognition underscores the company's commitment to advancing medical device technology in the healthcare sector.

The patent covers Tenon Medical's proprietary systems designed to stabilize sacroiliac joints, a critical area for patients suffering from related disorders. The allowance of this patent is a significant milestone for the company, enhancing its intellectual property portfolio and potentially opening new avenues for product development and market expansion.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time TNON sparks.

Download Sniper App →

Catch the next TNON-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →